APA (7th ed.) Citation

J, L., G, W., Z, L., X, L., Y, C., B, Y., . . . Y, Q. (2025). PRKAA2 mediates the pathogenesis of metabolic dysfunction-associated steatotic liver disease via PI3K/AKT signaling pathway. Human genomics, 19(1), 136. https://doi.org/10.1186/s40246-025-00854-2

Chicago Style (17th ed.) Citation

J, Li, et al. "PRKAA2 Mediates the Pathogenesis of Metabolic Dysfunction-associated Steatotic Liver Disease via PI3K/AKT Signaling Pathway." Human Genomics 19, no. 1 (2025): 136. https://doi.org/10.1186/s40246-025-00854-2.

MLA (9th ed.) Citation

J, Li, et al. "PRKAA2 Mediates the Pathogenesis of Metabolic Dysfunction-associated Steatotic Liver Disease via PI3K/AKT Signaling Pathway." Human Genomics, vol. 19, no. 1, 2025, p. 136, https://doi.org/10.1186/s40246-025-00854-2.